Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141475 |
| CAS No | NA |
| Mol.F. | C16H19FN4O5 |
| Mol.Wt. | 366.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141476 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O6S |
| Mol.Wt. | 428.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141477 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O4S |
| Mol.Wt. | 396.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141478 |
| CAS No | NA |
| Mol.F. | C8H5F2N3O2S |
| Mol.Wt. | 245.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141479 |
| CAS No | NA |
| Mol.F. | C32H27F4N7O9S2 |
| Mol.Wt. | 793.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141480 |
| CAS No | NA |
| Mol.F. | C32H26F4N8O10S2 |
| Mol.Wt. | 822.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141481 |
| CAS No | NA |
| Mol.F. | C16H19ClN2O3 |
| Mol.Wt. | 322.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141482 |
| CAS No | NA |
| Mol.F. | C24H29N9O2 |
| Mol.Wt. | 475.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141483 |
| CAS No | NA |
| Mol.F. | C23H27N9O2 |
| Mol.Wt. | 461.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141484 |
| CAS No | NA |
| Mol.F. | C15H18Cl2N4O3 |
| Mol.Wt. | 373.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141485 |
| CAS No | NA |
| Mol.F. | C12H12N4O3S |
| Mol.Wt. | 292.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141486 |
| CAS No | NA |
| Mol.F. | C13H10N4O4S |
| Mol.Wt. | 318.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141487 |
| CAS No | NA |
| Mol.F. | C15H17N5O4S |
| Mol.Wt. | 363.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141488 |
| CAS No | NA |
| Mol.F. | C17H21N5O4S |
| Mol.Wt. | 391.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141489 |
| CAS No | NA |
| Mol.F. | C15H16N4O5S |
| Mol.Wt. | 364.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141490 |
| CAS No | NA |
| Mol.F. | C12H10N2O2 |
| Mol.Wt. | 214.2 |
| INV STATUS | CUSTOM SYNTHESIS |